Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication

Molecular Neurobiology
Sanaz NasoohiTauheed Ishrat

Abstract

Neurological diseases, including acute attacks (e.g., ischemic stroke) and chronic neurodegenerative diseases (e.g., Alzheimer's disease), have always been one of the leading cause of morbidity and mortality worldwide. These debilitating diseases represent an enormous disease burden, not only in terms of health suffering but also in economic costs. Although the clinical presentations differ for these diseases, a growing body of evidence suggests that oxidative stress and inflammatory responses in brain tissue significantly contribute to their pathology. However, therapies attempting to prevent oxidative damage or inhibiting inflammation have shown little success. Identification and targeting endogenous "upstream" mediators that normalize such processes will lead to improve therapeutic strategy of these diseases. Thioredoxin-interacting protein (TXNIP) is an endogenous inhibitor of the thioredoxin (TRX) system, a major cellular thiol-reducing and antioxidant system. TXNIP regulating redox/glucose-induced stress and inflammation, now is known to get upregulated in stroke and other brain diseases, and represents a promising therapeutic target. In particular, there is growing evidence that glucose strongly induces TXNIP in multiple...Continue Reading

References

Sep 1, 1994·Journal of Neurochemistry·M GerlachM B Youdim
Feb 1, 1995·Seminars in Cancer Biology·C O BellamyA H Wyllie
Jun 1, 1996·Stroke; a Journal of Cerebral Circulation·P H Chan
Mar 20, 1998·Stroke; a Journal of Cerebral Circulation·T Kristián, B K Siesjö
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y TakagiJ Yodoi
May 3, 2000·The European Journal of Neuroscience·E RybnikovaM Pelto-Huikko
Jun 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E JunnI Choi
Nov 4, 2000·Clinical Pharmacology and Therapeutics·J N de HoonL M Van Bortel
Dec 26, 2001·Nature Genetics·Jackie S BodnarAldons J Lusis
Sep 17, 2002·Antioxidants & Redox Signaling·Akira MitsuiJunji Yodoi
Sep 3, 2003·Biochemical and Biophysical Research Communications·Kosuke AzumaMasako Mitsumata
Feb 10, 2004·Biochemical and Biophysical Research Communications·Kun-Yong KimInpyo Choi
May 7, 2004·The Journal of Biological Chemistry·P Christian SchulzeRichard T Lee
Feb 3, 2005·Cell Research·Tyler Zarubin, Jiahuai Han
Jun 21, 2005·Annals of the New York Academy of Sciences·Pak H Chan
Aug 23, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Glendon M ZinserJoEllen Welsh
Oct 26, 2005·Biochemical Society Transactions·A HolmgrenC H Lillig
Dec 17, 2005·Journal of Applied Physiology·Helene Girouard, Costantino Iadecola
Jan 13, 2006·The Journal of Biological Chemistry·Dongmei WangJunji Yodoi
Apr 4, 2006·Cellular Signalling·Roland KaunasShu Chien
Apr 12, 2006·Oncogene·S S ShethA J Lusis
Jun 8, 2006·Annual Review of Biochemistry·Pär Nordlund, Peter Reichard
May 3, 2007·PLoS Medicine·Hemang ParikhVamsi K Mootha

❮ Previous
Next ❯

Citations

Jun 4, 2020·Phytotherapy Research : PTR·Milad AshrafizadehKwang Seok Ahn
Sep 21, 2018·Frontiers in Molecular Neuroscience·Bo-Zong ShaoChong Liu
Sep 30, 2020·Proceedings of the National Academy of Sciences of the United States of America·Youjin HuWei Chi
Jan 13, 2019·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Lili FuSusu Tang
Feb 20, 2020·The International Journal of Neuroscience·Zhonghao SuZhenxia Qin
Oct 27, 2018·Frontiers in Molecular Neuroscience·Michael B MargineanuPierre J Magistretti
Jan 31, 2020·BioMed Research International·Farouk K El-BazRania A A Salama
Dec 29, 2020·Journal of Advanced Research·Abdullah Al MamunJian Xiao
Feb 12, 2021·International Journal of Molecular Sciences·Alison DominguesValérie Nivet-Antoine
Dec 5, 2020·Oxidative Medicine and Cellular Longevity·Xiaoqiang XiaoHaoyu Chen
Feb 1, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Xiao HeLiming Zhang
Jan 12, 2021·Frontiers in Pharmacology·Mengmeng WangLan Han
Apr 4, 2021·International Journal of Molecular Sciences·Naila QayyumSangdun Choi
May 25, 2021·Neurobiology of Disease·Saifudeen IsmaelTauheed Ishrat
Jun 22, 2021·Neurochemistry International·Saifudeen IsmaelTauheed Ishrat
Jul 6, 2021·Annals of Neurology·Jan D LünemannManuel Comabella

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
transfection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.